Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-24-015363

Chief Commercial Officer bought 30,000 shares at $5.47 ($164,100)

From the SEC's structured data for this filing

Trades in this filing

Gayer Charles K · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-13 Purchase : show line 1 in the form +30,000 $5.47 $164,100 307,533 D
Open-market purchases · 30,000 sh · avg $5.47 · $164,100
Loading xslF345X05/form4.xml…